NCT02447952
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- GSK Investigational Site London, United Kingdom
- GSK Investigational Site Oxford, United Kingdom
Clinical trial condition
Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.
NCT02447952
NCT02709330
NCT02469675
NCT02750982
NCT01160367
NCT02306109
NCT03618966
Not specified
NCT02537132
NCT03073239
NCT01995903